Generic versus disorder specific cognitive behavior therapy for social\ua0anxiety disorder in youth: a randomized controlled trial using\ua0internet delivery by Spence, Susan H. et al.
Accepted Manuscript
Generic versus disorder specific cognitive behavior therapy for social anxiety disorder
in youth: A randomized controlled trial using internet delivery
Susan H. Spence, Caroline L. Donovan, Sonja March, Justin Kenardy, Cate Hearn
PII: S0005-7967(16)30212-1
DOI: 10.1016/j.brat.2016.12.003
Reference: BRT 3063
To appear in: Behaviour Research and Therapy
Received Date: 15 June 2016
Revised Date: 14 October 2016
Accepted Date: 5 December 2016
Please cite this article as: Spence, S.H., Donovan, C.L., March, S., Kenardy, J., Hearn, C., Generic
versus disorder specific cognitive behavior therapy for social anxiety disorder in youth: A randomized
controlled trial using internet delivery, Behaviour Research and Therapy (2017), doi: 10.1016/
j.brat.2016.12.003.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
Generic versus Disorder Specific Cognitive Behavior Therapy for Social Anxiety 
Disorder in Youth: A Randomized Controlled Trial Using Internet Delivery 
 
 
Susan H. Spence (PhD)a 
Caroline L. Donovan (PhD)b 
Sonja March (PhD)c 
Justin Kenardy (PhD)d 
Cate Hearnb 
 
a
 Australian Institute of Suicide Research and Prevention (AISRAP) and School of Applied 
Psychology, Griffith University, Mount Gravatt Campus, Mount Gravatt, QLD, Australia, 4122 
 
b
 School of Applied Psychology and the Menzies Health Institute Queensland, Griffith University, 
Mount Gravatt Campus, QLD, Australia, 4122 
 
c
 School of Psychology and Counselling & Institute for Resilient Regions, University of Southern 
Queensland, Springfield, QLD, Australia, 4300 
 
d Recover Injury Research Centre, School of Medicine, The University of Queensland, Brisbane, 
Queensland, Australia 
 
Corresponding author: Susan H Spence, Australian Institute of Suicide Research and Prevention, 
Griffith University, Mount Gravatt Campus, QLD, Australia, 4122; TEL +61 412 119 367 
Email: s.spence@griffith.edu.au 
Note: ACTRN12611000901909, This work was supported by the National Health and Medical 
Research Council (Project number 1008319), Australia 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
ABSTRACT 
The study examined whether the efficacy of cognitive behavioral treatment for Social 
Anxiety Disorder for children and adolescents is increased if intervention addresses specific 
cognitive and behavioral factors linked to the development and maintenance of SAD in young 
people, over and above the traditional generic CBT approach.  
Participants were 125 youth, aged 8-17 years, with a primary diagnosis of SAD, who 
were randomly assigned to generic CBT (CBT-GEN), social anxiety specific CBT (CBT-
SAD) or a wait list control (WLC). Intervention was delivered using a therapist-supported 
online program.  
After 12-weeks, participants who received treatment (CBT-SAD or CBT-GEN) 
showed significantly greater reduction in social anxiety and post-event processing, and greater 
improvement in global functioning than the WLC but there was no significant difference 
between CBT-SAD and CBT-GEN on any outcome variable at 12-weeks or 6-month follow-
up. Despite significant reductions in anxiety, the majority in both treatment conditions 
continued to meet diagnostic criteria for SAD at 6-month follow-up. Decreases in social 
anxiety were associated with decreases in post-event processing. 
Future research should continue to investigate disorder-specific interventions for SAD 
in young people, drawing on evidence regarding causal or maintaining factors, in order to 
enhance treatment outcomes for this debilitating condition.    
 
KEYWORDS:  
Social Anxiety Disorder; Social Phobia, Children and Adolescents; Disorder-specific; Post-
event Processing; Cognitive Behavior Therapy 
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1. Introduction 
Social Anxiety Disorder (SAD: previously Social Phobia) is one of the most common 
anxiety disorders experienced by young people, with lifetime prevalence rates estimated at 
8.6% (Burstein et al., 2011; Lawrence et al., 2015). According to DSM-5 (American 
Psychiatric Association, 2013), the core defining features of SAD include fear or anxiety in 
social situations where the individual is exposed to possible scrutiny by others and a fear of 
acting in a way that will be negatively evaluated by others (either resulting from the 
individual’s own behavior or from showing anxiety symptoms such as blushing, trembling or 
sweating). Young people with SAD fear situations such as school talks, sport and musical 
performances, as well as social interactions such as meeting new people, joining in 
conversations, asking for help in shops or at school, and going to parties or other gatherings 
(Beidel et al., 2007; Rao et al., 2007). Although the average age of onset is around 9.2 years 
(Burstein et al., 2011), children as young as three years of age have been found to experience 
SAD (Rapee et al., 2010). Unfortunately, the disorder tends to persist if left untreated 
(Burstein et al., 2011; Weissman et al., 1999), with onset prior to age 11 years of age 
increasing the risk of persistence into adulthood (Beesdo et al., 2007; Wittchen & Fehm, 
2003). 
The experience of SAD in young people is associated with numerous deleterious 
social, academic and psychological consequences, such as loneliness, depression, friendship 
problems, and school refusal (Beidel, Turner, & Morris, 1999). SAD in youth is comorbid 
with a significant number of mental health problems, particularly other anxiety disorders and 
depression, and with substance use in older adolescents (Beesdo-Baum et al., 2012; Burstein 
et al., 2011; Wittchen, Stein, & Kessler, 1999). Some longitudinal studies suggest that SAD 
actually precedes some mental health issues, being a risk factor for later substance abuse and 
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depression (Beesdo et al., 2007; Black et al., 2015). Thus, early intervention is of utmost 
importance so that long-term adverse consequences can be averted. 
The majority of studies examining the impact of cognitive behavioral therapy (CBT) 
in the treatment of anxiety disorders, including SAD, have involved a generic approach that 
targets underlying causal and maintaining problems that are common to a range of anxiety 
disorders. Therapy components typically include psycho-education about anxiety, coping 
strategies (e.g. relaxation; problem solving; identification and modification of maladaptive 
thoughts) and graded exposure to feared situations. These interventions are generally 
manualized and the same intervention content is used irrespective of the presenting anxiety 
problem (Barrett, Lowry-Webster, & Turner, 2000; Kendall & Hedtke, 2006; Rapee, Abbott, 
& Lyneham, 2006; Rapee et al., 2000; Silverman et al., 1999; Waters et al., 2009).  
Overall, there is a good deal of evidence to support the efficacy of a generic approach 
in treating anxiety disorders, with a recent meta-analysis indicating significant benefits 
(Bennett et al., 2013). However, recent studies suggest that outcomes following such 
interventions are weaker for youth with SAD than for other types of anxiety disorders. 
Children with SAD typically demonstrate a slower rate of change and are less likely to be free 
of a SAD diagnosis after treatment compared to youth with other anxiety disorders (Crawley 
et al., 2008; Ginsburg et al., 2011; Hudson, Keers, et al., 2015; Hudson, Rapee, et al., 2015; 
Norton & Price, 2007). Indeed, in a collation of data from multiple sites, Hudson, Keers, et al. 
(2015) found that children with a primary diagnosis of SAD were nearly twice as likely as 
children with GAD to retain their primary diagnosis immediately after generic CBT and at 12-
month follow-up. Similarly, Hudson, Rapee, et al. (2015) in a study of 842 children with 
anxiety disorders found that only 22.3% and 30.7% of those with a primary diagnosis of SAD 
were free of this diagnosis after treatment and at follow-up respectively. In comparison, over 
40% of children with other types of primary anxiety diagnosis were free of their primary 
diagnosis after treatment, which increased to around 56-57% by 3 to 12 month follow-up. The 
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weaker treatment outcomes for children with SAD could not be explained by differences in 
age nor comorbid depression.  
It is important to consider why children with SAD might respond less favourably to 
generic anxiety treatments compared to youth with other types of anxiety disorders. One 
possibility is that the generic approach does not focus sufficiently upon changing the 
cognitive and behavioral factors that are involved in the development and maintenance of 
SAD. A recent empirical review by (Spence & Rapee, 2016) noted that while SAD is 
associated with many of the risk factors linked to other types of anxiety disorder, such as 
parental over-control and over-protection (Ollendick, Benoit, & Grills-Taquechel, 2014) and 
adverse life events (Bögels & Brechman-Toussaint, 2006; McLaughlin et al., 2012), research 
also indicates that there are unique factors that are important in explaining the development 
and maintenance of SAD specifically. For example, Spence and Rapee (2016) reviewed 
evidence to show that young people with SAD are more likely to show deficits in social skills 
and to experience adverse social outcomes than non-anxious children or those with other 
types of anxiety disorder. They tend to have fewer friends, to be less well-liked by peers, and 
to be neglected, actively rejected and victimized by peers. Spence and Rapee (2016) expanded 
current adult theories of the maintenance of SAD (Clark & Wells, 1995; Rapee & Heimberg, 
1997) to propose an evidence-based model of the development and maintenance of SAD 
during childhood and adolescence. This model proposed that a vicious cycle develops in 
which poor social skills tend to lead to adverse social outcomes that, in turn, result in anxious 
emotions, avoidance behaviors, and maladaptive beliefs and thoughts relating to one’s social 
competence and social interactions. In response to adverse social experiences, young people 
come to believe that they are deficient, stupid, and unattractive, with little ability to control 
the outcomes of social situations. They come to regard other people as highly critical, with 
extremely high standards, and who observe their every action (an “audience” effect). Such 
maladaptive beliefs about the self and others are proposed to contribute to a range of cognitive 
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biases and distortions before, during and after challenging social interactions, including biases 
in attention, expectations, interpretations, and evaluations. Increased vigilance to social 
situations, expectations that one will perform in a humiliating or embarrassing way, beliefs 
that others will appraise and respond negatively, and expectations that the outcome of social 
situations will be terrible, are all suggested to contribute to the further experience of anxiety. 
Furthermore, high levels of self-focused attention and consequential distraction away from the 
social task are likely to impair social performance. After social interactions, socially anxious 
individuals tend to interpret the response of others and the quality of their own performance as 
being worse than it actually is. They are also likely to engage in maladaptive post-event 
processing (PEP) which refers to the tendency to recall and ruminate about perceived negative 
aspects of previous social situations. Not surprisingly, feared social interactions are likely to 
be avoided where possible. Such avoidance, in combination with rejection and isolation by 
peers, may serve to reduce opportunities for further learning and practice of social skills. 
Thus, the cycle is perpetuated.   
Generic CBT approaches for treating child and adolescent social anxiety assume that 
the psycho-education, cognitive restructuring, coping skills, and exposure components of 
treatment will be sufficient to address the factors that maintain SAD. We propose in the 
present paper that the treatment of SAD in youth is more likely to be effective if the 
intervention focuses more specifically upon the cognitive and behavioral factors that are 
implicated in its development and maintenance. We acknowledge that generic CBT programs 
for child anxiety include elements to increase awareness and modification of maladaptive 
cognitions before, during and after challenging social interactions, but they do not typically 
include information about self-focussed attention, with exercises to shift attention focus from 
the self to the social task, nor provide specific training in the reduction of post-event 
processing.  Neither do they include systematic content to enhance social skills.  
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With children and adolescents, several studies have evaluated CBT interventions for 
SAD that included social skills training (Albano et al., 1995; Beidel, Turner, & Morris, 2000; 
Donovan et al., 2015; Garcia-Lopez et al., 2006; Masia Warner et al., 2007; Olivares et al., 
2002; Ost, Cederlund, & Reuterskiold, 2015; Spence, Donovan, & Brechman-Toussaint, 
2000). A recent meta-analysis reported by Scaini et al. (2016) noted that the effects of 
interventions that included social skills training tended to be more effective than those that did 
not. However, examination of effect sizes associated with the CBT interventions that included 
social skills training suggest that there is still considerable room for improvement and studies 
have not directly compared the generic approach with that including social skills training.  
In terms of attempts to change the maintaining cognitive factors of SAD, Melfsen, 
Kühnemund, et al. (2011) developed and evaluated an intensive cognitive therapy intervention 
for youth aged 8-14 years based on the Clark and Wells (1995) model. This approach differed 
from the cognitive challenging element included in most generic CBT treatments for 
childhood SAD in that it included a) methods to addess the child’s own thoughts, images, 
attentional strategies, safety behaviors and symptoms specifically related to social anxiety, b) 
experiential exercises to reduce self-focused attention and safety behaviors and to illustrate 
their maladaptive effects, c) systematic training in externally focused attention, d) strategies 
aimed at reducing distorted self-imagery, and e) exposure to feared situations as behavioral 
experiments in which the validity of negative expections is tested, while omitting habitual 
safety behaviors and self-focused attention. After twenty, 50-min individual sessions and 4 
parent sessions, 33% of youth in the cognitive therapy condition compared to 0% in the 
waitlist condition were free of their SAD diagnosis. Those in the cognitive therapy condition 
also showed significantly greater reductions in social anxiety symptoms and socially anxious 
cognitions than the waitlist. Unfortunately, there was no follow-up and therefore it is not 
known whether these effects were maintained or improved upon over time. There was also no 
comparison with generic CBT.  
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Ingul, Aune, and Nordahl (2013) subsequently compared the effects of individually 
tailored and delivered cognitive therapy based on the Clark and Wells model, with traditional 
group-based generic CBT, and with an active placebo (social interaction group) in adolescents 
with SAD. After treatment, 70%, of the individual cognitive therapy, 21% of the traditional 
group CBT, and 28% of the attention placebo conditions showed reliable, clinical reductions 
in social anxiety symptoms. At 12-month follow-up, 73% of the individual cognitive therapy 
and 53% of group CBT conditions had no SAD diagnosis, although this difference was not 
statistically significant. It is difficult to draw firm conclusions from this study, however, as it 
confounded mode of delivery (group versus individual delivery) and content of treatment. 
Nevertheless, the results are consistent with the view that modifying the negative perceptual 
and processing biases associated with SAD provides relatively strong and lasting reductions 
in SAD symptoms.  
Although the studies reviewed above reveal positive outcomes for SAD treatments in 
young people that include social skills training, or that include cognitive components, in 
comparison to no-intervention or waitlist control, the results suggests that there is still room 
for improvement. Thus, the question remains as to whether treatment designed specifically to 
tackle both cognitive and behavioral causal and maintaining factors associated with SAD will 
be more effective than traditional generic CBT approaches. We propose here that effective 
intervention for SAD needs to address both aspects. To date, the efficacy of SAD-specific 
therapy that combines both cognitive and behavioral components is yet to be compared with 
generic CBT with socially anxious children and adolescents. However, a study by Rapee, 
Gaston, and Abbott (2009) with adult social phobics showed significantly larger effects for an 
intervention that specifically targeted the cognitive and behavioral maintaining factors of 
SAD compared with a more traditional cognitive behavioral program. 
The aim of the present study was to compare the relative efficacy of traditional generic 
CBT for youth anxiety with a SAD-specific intervention that aimed to tackle the cognitive 
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and behavioral factors associated with SAD. Specifically, the intervention included social 
skills training, and modification of self-focused attention and maladaptive cognitions that 
occur before, during and after feared social interactions. The mode of delivery, number of 
treatment sessions, and number of therapy tasks was held constant across treatment 
conditions. Treatment was delivered on an individual basis using internet delivery, with brief 
therapist support. The use of online delivery of treatment in the present study was intended to 
enable us to reach the sufficiently large sample of young people required to compare effects 
across active interventions. The efficacy of the therapist-assisted, online generic CBT 
program for youth anxiety used in the current study has been demonstrated in several 
randomized controlled trials (eg. March, Spence, & Donovan, 2009; Spence et al., 2011; 
Spence et al., 2006). These studies demonstrated significantly greater reductions in anxiety for 
the online-program compared to a waitlist control, with effects maintained or further 
enhanced during follow-up (March et al., 2009). Benefits were also equivalent to those found 
from clinic-delivery of generic CBT, with approximately 78% of those receiving the internet 
intervention being free of their primary diagnosis at 12-month follow-up (Spence et al., 2011). 
It should be noted that participants in these studies presented with one or more anxiety 
disorders of varying types, including some with SAD.  
There is also a strong case for use of the internet to deliver social skills training as it 
can be used to present i) information about the nature and importance skills in an interactive 
manner, ii) videotaped illustrations specific skill usage by other young people, iii) instructions 
for practice in real world contexts, and iv) monitoring charts for homework completion. 
Although not specifically evaluated with children with SAD, computer or internet delivery of 
social skills training has been shown to produce significant improvements in social skills with 
children in regular classrooms and youth with autism spectrum disorders (Beaumont, 
Rotolone, & Sofronoff, 2015; Craig et al., 2015; Sanchez et al., 2014; Tan, Mazzucchelli, & 
Beaumont, 2015).  
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Specifically, we proposed that in comparison to generic CBT, treatment outcomes 
would be greater for an CBT intervention for youth anxiety that included social skills training, 
cognitive therapy components that focus specifically upon reducing self-focused attention, 
and greater focus on reducing maladaptive pre- and post-event processing of social tasks. We 
hypothesised that, at 12-week assessment and 6-month follow-up, children receiving the 
SAD-specific treatment program would show greater reductions in SAD symptoms, lower 
rates of SAD diagnoses, and greater improvements in global functioning than children 
receiving the generic program. Both active interventions were predicted to show significantly 
greater improvements on these measures than the waitlist control group at 12-week 
assessment.  
The study also predicted that the SAD-specific intervention would result in significantly 
greater improvements in the variables that it aimed to change (as assessed by measures of 
social skills and PEP), than the generic CBT approach or the WLC. In turn, we proposed that 
changes in social skills and PEP would be associated with reductions in social anxiety.  
Method 
1.1.  Participants 
 Participants were 125 youth (75 females, 50 males) aged between 8-17 years (M = 
11.28, SD = 2.68) who met DSM-5 (American Psychiatric Association, 2013) criteria for a 
primary diagnosis of SAD on the Anxiety Disorder Interview Schedule for Children (ADIS-
C/P; Albano and Silverman, 1996; see below for details). Details about demographic 
characteristics are provided in Table 1. The demographic profile of the sample was broadly 
representative of the Australian census population in terms of country of origin and 
indigenous status, but of higher average income.  
Selection criteria included being aged 8-17 years; minimum reading age of 8 years; 
speaking English fluently; having access to a computer and the internet; and meeting DSM-5 
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criteria for a primary diagnosis of SAD at a clinical severity rating (CSR) of 4 or more (on a 
scale from 0-8) according to the ADIS-C/P. Comorbidity with other anxiety disorders, 
depression and externalising disorders was permissible if the CSR was lower than that of the 
SAD diagnosis. Exclusion criteria included diagnosis of a pervasive developmental disorder, 
presence of an intellectual or learning disability, diagnosis of dysthymia or depression at a 
CSR of 5 or higher, other acute psychiatric disorders (such as psychosis or suicide ideation), 
and receipt of other current treatment for anxiety. Information about baseline levels of social 
anxiety, global functioning and comorbidity is provided in Table 1. 
1.2. Procedure  
 Ethical approval was granted from the Griffith University Human Research Ethics 
Committee. Participants were self-referred and recruited across Australia via schools, parent 
groups, mental health professionals, guidance officers, the media and Facebook. Those 
meeting telephone screening criteria were directed to an online site to obtain additional 
information and provide informed consent to participate. The child and participating 
parent/caregiver then completed a structured diagnostic interview by telephone and online 
questionnaires (see below for details). Once pre-treatment assessments were completed and 
inclusion criteria confirmed, children were randomly assigned to condition using a 
computerized random number generation, to one of three conditions: generic CBT (CBT-
GEN), SAD-specific CBT (CBT-SAD) or a waitlist control (WLC). There were two versions 
of both CBT-GEN and CBT-SAD, one for children aged 8-12 years, and one for teenagers 
aged 13-17 years. The program content of the different age versions was identical but the 
language and examples were designed to be age appropriate.  
The CONSORT statement for participants at each stage of the study is presented in 
Figure 1. As is evident from Figure 1, of the 48 participants allocated to the CBT-SAD 
condition, 31 were allocated to the child version of the program (8-12 years), and 16 to the 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
teen version (13-17 years). Of the 47 youth allocated to the CBT-GEN condition, 30 were 
allocated to the child version and 18 to the teen version. Of the 30 youth allocated to the WLC 
condition there were 18 categorized as children and 12 as teens.  After the 12-week 
assessment, participants in the WLC group were offered CBT-SAD and no longer formed part 
of the study.  
1.3.  Measures 
1.3.1.  Primary outcome measures - diagnostic status, clinical severity and global 
functioning.   
Diagnostic status and the Clinican Severity Rating (CSR) - were derived from the 
Anxiety Disorders Interview Schedule for Children (ADIC C/P Albano & Silverman, 1996). 
The ADIS C/P was administered by telephone at all time-points by trained psychologists, with 
provisional registration, who were blind to experimental condition. Prior to determining 
diagnoses, clinicians compared the ADIS C/P interview information against DSM-5 criteria, 
and therefore all diagnoses given in this study align with DSM-5 criteria. Diagnoses and 
CSRs were based on a composite of parent and child interviews as specified by Albano and 
Silverman (1996).  Where children met criteria for a diagnosis, a CSR was allocated from 4 to 
8, with 0 being the CSR for those who did not meet diagnostic criteria.  Inter-assessor 
agreement was assessed in the present study for 20% of interviews. High inter-rater 
agreement was found for the ADIS-C/P composite primary diagnosis with a kappa = .84, with 
an inter-rater reliability Cronbach alpha of .98 and intra-class correlation of .96 for the CSR.  
Global functioning was assessed by clinicians using the Children’s Global Assessment 
Scale (CGAS; Shaffer et al., 1983) informed by the ADIS C/P interviews. Scores on the 
CGAS can range from 1-100, with higher scores indicating better overall functioning. Scores 
of 81-100 indicate healthy functioning, scores of 61-80 indicate slight impairment, scores of 
41-60 suggest moderate impairment, and scores of 1-41 indicate a seriously disabling 
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functional impairment. The CGAS has been found to be a valid and reliable instrument, with 
an inter-rater reliability of .84 and a six-month test-retest reliability of .85 (Shaffer et al., 
1983).  Inter-rater reliability was determined using the same procedure as for the ADIS, 
revealing a Cronbach alpha of .90 and intra-class correlation of .80 for CGAS between 
independent raters.  
1.3.2. Secondary outcome measures 
Clinical improvement –was assessed with the Clinical Global Impression: Improvement 
Scale (CGI-IS; Guy, 1976). Scores range from 1 (“very much improved since the initiation of 
treatment”) to 7 (“very much worse since the initiation of treatment”). The CGI-IS correlates 
well with other treatment efficacy scales for disorders affecting adults, including SAD 
(Bandelow et al., 2006), and has been shown to be sensitive to treatment effects in children 
and adolescents with SAD (Compton et al., 2001). 
Social anxiety symptoms – were measured with child and parent report on the 10-item 
version of the Social Phobia and Anxiety Inventory for Children (SPAI-C: Beidel, Turner, & 
Morris, 1995- Personal communication, 2012). The SPAI-C-10 consists of 10 items relating 
to cognitive, somatic and behavioral aspects of social anxiety, eight of which require 
subsidiary ratings. In total, there are 29 ratings each made on a 3-point scale from 0 (“Never 
or hardly ever”) to 2 (Most of the time or always”) producing scores ranging from 0-58, with 
higher scores indicating greater social anxiety. Cronbach alphas for the SPAI-C-10 at baseline 
in the current study were .91 for the child version and .92 for the parent version. 
Anxiety symptoms – were assessed with the parent and child versions of the Spence Child 
Anxiety Scale (SCAS; Spence, 1998). The SCAS-C is a 44-item scale in which young people 
rate the frequency of symptoms on a 4-point Likert scale ranging from 0 (“never”) to 3 
(“always”). Total scores range from 0-114, with higher scores indicating greater anxiety 
symptoms. It has demonstrated good internal consistency for the total score, ranging from .89-
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.92 (Spence, 1998; Spence, Barrett, & Turner, 2003). The 38-item SCAS-P for parents (Nauta 
et al., 2004) also has scores ranging from 0 – 114, and demonstrates good psychometric 
properties. The internal consistency in this sample for the SCAS-C was .88 and for the SCAS-
P was .90.  
1.3.3. Treatment satisfaction.  
Satisfaction with the program was measured at 12-week assessment using a Treatment 
Satisfaction Questionnaire with 6-items for children and 8-items for parents adapted from 
March et al. (2009). Participants rated their satisfaction on a 5-point scale from 1 (“not at all 
true) to (“extremely true”), with scores being totaled and divided by the number of items, to 
produce a mean score ranging from 1 to 5. The Cronbach alphas in the current study were .94 
for the child scale and 0.92 for the parent scale. 
1.3.4. Cognitive and behavioral measures 
Social skills – were assessed with the 30-item Social Skills Questionnaire – Child and 
Parent Versions (Spence, 1995). Participants were required to rate how true each item is on a 
3-point scale from 0 (“not true”) to 2 (“mostly true”). Scores range from 0-60 with higher 
scores indicating better social skills. Examples of items from the child report version include 
“I ask other kids if I can join in their activities", "I look people in the eye when we are 
talking" "I tell a parent or teacher if I have a problem or need help", and "I stand up for myself 
if other kids behave badly towards me without losing my temper". The psychometric 
properties of the SSQ are sound, with coefficient alphas of .85 and .92 for the parent and child 
versions respectively (Spence, 1995). In the present study, Cronbach alphas were .85 for the 
SSQ-C and .91 for the SSQ-P at baseline.  The scale has been shown to be sensitive to 
treatment outcome effects (Beaumont et al., 2015; Spence et al., 2000) and socially anxious 
youth have been shown to exhibit weaker social skills on this measure compared to non-
anxious controls on both parent and youth report (Spence, Donovan, & Brechman-Toussaint, 
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1999). 
 Post-event processing - was assessed using the 8-item Post Event Processing 
Questionnaire Revised (PEPQ-R; McEvoy & Kingsep, 2006). Respondents were asked to 
think of a time in the past few months where they felt uncomfortable in a social situation and 
to rate the degree to which they engaged in each of 8 PEP activities (e.g., "After the event was 
over, did you find yourself thinking about it a lot?"). A visual analogue scale was used, 
ranging from 0 (not at all) to 100 (totally agree). Higher total scores indicate higher levels of 
repetitive thinking. Cronbach's alpha for the PEPQ-R in the present study was .87. 
1.4. Treatment 
1.4.1. Generic CBT.  
The CBT-GEN intervention (BRAVE-ONLINE) was previously developed and 
evaluated by Spence and colleagues (March et al., 2009; Spence et al., 2011) and was adapted 
from a clinic-delivered program that is highly consistent with other generic CBT programs for 
youth anxiety (Barrett et al., 2000; Kendall & Hedtke, 2006; Rapee et al., 2006; Rapee et al., 
2000; Silverman et al., 1999; Waters et al., 2009). It consists of 10 weekly, 60-minute 
sessions for children or youth, followed by two booster sessions at 1- and 3- months after 
completion of the program. There is a version for children aged 8-12 years and one for teens 
from 13-17 years, with identical therapy content but using age-appropriate wording, graphics 
and examples. Session content includes psycho-education about anxiety and its different 
types, anxiety management strategies such as recognizing body signs of anxiety, relaxation 
(deep breathing, progressive muscle relaxation, guided imagery), cognitive strategies 
including coping self-talk and cognitive restructuring, graded exposure, problem solving 
techniques, and self-reinforcement of “approach” behavior. There are also six parent sessions 
for parents of child participants, and five sessions for parents of teens, with parent booster 
sessions at 1- and 3- months post treatment. The CBT-GEN program includes information, 
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illustrations and exercises relating to a broad range of anxiety provoking situations, relevant 
to social, separation, and generalized anxiety and specific phobias.  
All sessions are interactive, with quizzes, puzzles and tasks. Prior to treatment, each 
family is assigned a therapist (BRAVE Trainer) who monitors their progress through the 
program and provides brief email feedback (taking approximately 5-10 mins each) following 
each session. Feedback is based on client responses to session and homework activities that 
are stored in an administrator section of the program that is accessible to the therapist. In 
addition, personalised, automated computer-generated emails are sent on behalf of the online 
therapist to congratulate participants for completing sessions, to provide feedback on quiz 
tasks and to send reminders when they are able to log on to complete the next session. The 
brief therapist support also included a single, 15 min telephone call mid-way through the 
program to assist with development of the exposure hierarchy. For further information about 
the program see March et al. (2009), Spence et al. (2006), and Spence et al. (2011). 
1.4.2. SAD-specific CBT.  
The CBT-SAD intervention mirrored CBT-GEN in terms of the number and duration of 
sessions, the number of web pages and activities, amount of time spent by youth and parents 
on the program, and the level of therapist support. Like CBT-GEN, CBT-SAD included 
psychoeducation, problem solving, relaxation training, graded exposure, and self-reward. 
However, in CBT-SAD these elements specifically focused on social anxiety, whereas the 
CBT-GEN included examples and activities relating to a range of anxiety problems. CBT-
SAD also included elements to tackle specific factors associated with the development and 
maintenance of SAD outlined above. Firstly, it included social skills training using 
instructions and explanations about the nature and importance of social skills, videotaped 
illustrations, and behavioral rehearsal tasks between sessions. Training covered basic social 
skills (such as eye contact, voice volume, facial expression) and more complex social skills 
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(such as starting conversations, making requests, joining in, offering invitations, and assertive 
responding e.g. dealing with unreasonable requests).  Secondly, the intervention included 
more intensive cognitive elements relevant to social phobia than the cognitive components of 
CBT-GEN, in line with Melfsen, Kuhnemund, et al. (2011), and based on the Clark and Wells 
(1995) model. Specifically these strategies included  a) a stronger focus on the child’s own 
symptoms, thoughts (before/during/after a social task), attentional strategies, and avoidance 
behaviors related to social anxiety, b) to illustrate the maladaptive effects of self-focussed 
attention, with experiential exercises to reduce self-focused attention and increase attention 
externally to the social task, and c) exposure tasks emphasing externally focused attention, 
reducing self-focused attention and use of social skills, in addition to cognitive challenging 
and use of coping skills. 
1.4.3. Therapists and supervision.  
All therapists were psychologists who had received a minimum of two days training with 
the BRAVE-ONLINE materials.  In addition, therapists were provided with weekly 
supervision from an experienced clinical psychologist.  During supervision, the therapist’s 
online responses were reviewed in order to maintain a high standard of integrity and to ensure 
that each therapist was adhering to all guidelines for participant contact (e.g., length and 
content of session responses, adhering to templates).  
1.4.4. Treatment compliance.  
Compliance with treatment was assessed from the mean number of sessions completed 
by participants in each condition. Participants were not able to commence a subsequent 
session unless they had completed all material and tasks from the previous session. 
1.5. Statistical analyses 
Continuous outcome variables and percent diagnosis free were analysed using orthogonal 
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planned contrasts; (i) treatment versus WLC and (ii) CBT-SAD vs CBT-GEN), with linear 
mixed models containing random effects for subject and fixed effects for condition and time 
(with time as a repeated effect), using maximum likelihood estimates. This approach uses all 
available data with no imputation of missing values, which are assumed to be missing at 
random. Little’s MCAR test confirmed that the data fulfilled the requirements for this 
analysis, being missing completely at random. Thus, in these analyses, all participants 
allocated to conditions were included, irrespective of completer status, reflecting an intent-to-
treat (ITT) approach. For the data set for pre-treatment to 12-weeks, 8.92% of data points 
were missing across the three experimental groups (CBT-GEN, CBT-SAD and WLC), but 
this increased to 16.29% for the pre-treatment to 6-months analyses between CBT-GEN and 
CBT-SAD. Effect sizes were calculated as the estimated fixed effect divided by the square 
root of the sum of the two variance components. Interaction effects with age and gender were 
also examined in subsidiary analyses but were not statistically significant and thus are not 
reported here. The proportion of participants who no longer met criteria for the principal 
diagnosis and any diagnosis was determined using Chi Square tests. This analysis was 
conducted separately for the ITT sample and then for the retained sample. For the ITT 
sample, participants without assessment data at a given time point were assumed to possess 
the diagnoses that were allocated at the prior assessment point. For the “retained” sample, the 
analysis was limited to those for whom diagnostic data was available at the 12-week 
assessment and for whom the child or parents had completed at least 3 sessions. 
It was not possible to conduct tests of longitudinal mediation due to the absence of the 
WLC at follow-up, and in order to infer causal mediation time should elapse between a 
putative cause and its hypothesized effect (Preacher, 2015). Thus, we limited the analyses to 
cross-sectional mediation tests from baseline to 12-weeks with youth who completed (or their 
parent/caregiver completed) at least 3 intervention sessions and who provided 12-week 
assessment data to determine whether reductions in anxiety were associated with changes in 
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PEP or social skills. These analyses used the PROCESS macro for SPSS (Hayes, 2013) to 
determine whether changes in social skills or PEP (M) mediated changes in anxiety (Y) in 
response to treatment (X, CBT-SAD vs CBT-GEN). This approach used a non-parametric, 
accelerated bootstrapping method (1000 random samples of the available data) to determine 
the cross-products of the coefficients of the paths from treatment to mediator (X->M; “a”) and 
mediator to change in anxiety (M-> Y, “b”) thereby overcoming issues relating to non-normal 
distributions and small sample sizes. Bias-corrected and accelerated bootstrapped confidence 
intervals of indirect effects are produced. Statistical significance of the indirect effect is 
concluded when the confidence interval of the indirect effect does not include 0. Residual 
change scores were used as indicators of change over time for clinical outcomes and potential 
mediators because they adjust for pre-treatment variance and control for the correlation 
between pre- and 12-week scores (Manning & Du Bois, 1962).  
2. Results 
2.1.  Pre-treatment differences 
There we no pre-treatment differences between any of the three experimental groups on 
any of the demographic variables (see Table 1 for a summary). There were no significant 
differences between groups at pre-treatment for diagnostic data or measures of SAD symptom 
severity on the CSR, CGAS, number of comorbid diagnoses, SPAI-C or SPAI-P, anxiety 
severity on SCAS-C and SCAS-P, social skills on SSQ-C and SSQ-P, or PEPQ-R.  
2.2.   Attrition.  
The Consort statement (Figure 1) shows the retention of participants during the study. At 
the 12-week assessment there was 21% (N=10) attrition from CBT-SAD (including 3 
allocated but failed to commence treatment); 29% (N=14) from CBT-GEN and 10% (N=3) 
from the WLC. Attrition figures included those who were randomly allocated to a condition 
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but who failed to provide data at an assessment point and/or for those in a treatment condition 
for whom the parent and child both failed to complete at least 3 intervention sessions. A 
comparison of those retained versus those not retained at 12-week assessment revealed no 
significant differences in terms of age, gender, or other demographic variable, CSR, CGAS, 
number of diagnoses, or other clinical measure. At 6-month follow-up there was 38% (N=18) 
attrition from CBT-SAD and 31% (N=13) from CBT-GEN.  
2.3. Primary outcome measures at 12-week assessment and 6-month follow-up 
The estimated means and standard errors for the CSR and other continuous variables 
for each group at each occasion are shown in Tables 2 - 4, with details regarding effect sizes 
and confidence intervals presented in Tables 3 - 7. 
2.3.1.   Clinician Severity Rating.  
Linear mixed model analysis for the ITT sample from pre- to 12-week assessment 
indicated a significant difference in change in CSR between those receiving treatment (CBT-
SAD or CBT-GEN) vs WLC, F = 14.22 (118.97), p <.001, with no significant overall group 
effect, but a significant effect for time,  F = 4.17 (127.49), p =.043. The comparison between 
CBT-SAD and CBT-GEN revealed no significant difference in change in CSR over time, and 
no overall effect for condition, but a significant reduction in CSRs for treatment in general, F 
= 112.75 (92.22), p <.001. Comparison of CBT-SAD vs CBT-GEN from baseline to 6-month 
follow-up indicated a significant decrease in CSR for treatment in general, F = 209.54 
(94.04), p <.001 but no significant difference in change in CSR between treatments.  
2.3.2. Diagnosis.  
For the ITT sample, there was no significant difference between conditions in terms of 
percent free of their primary diagnosis, χ2 (2) = 2.35, p = .28 at the 12-week assessment 
(CBT-SAD=6/47 (12.8%); CBT-GEN=7/48 (14.6%) and WLC=1/30 (3.3%)). The ITT 
analysis for 6-month follow-up data showed 14/47 (29.8%) and 17/48 (35.4%) of the CBT-
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SAD and CBT-GEN conditions respectively to be free of their primary SAD diagnosis, with 
no significant difference between treatments.  
For the retained sample, the combined treatments showed a significantly higher percent 
free of their primary anxiety diagnosis compared to WLC, at 12-weeks, χ2 (1) = 3.89, p = .05, 
but no significant difference between treatments (CBT-SAD=6/35 (17.1%); CBT-GEN=7/34 
(20.6%) and WLC=1 (3.7%)). At follow-up 14/27 (51.9%) and 16/34 (47.1%) for those in 
CBT-SAD and CBT-GEN conditions respectively were free of their primary SAD diagnosis, 
with no significant difference between conditions. Figures for percent free of any diagnosis 
are also shown in Table 2.  
2.3.3. Global functioning.  
For the CGAS, from pre- to 12-weeks, significantly greater improvement was found for 
those receiving treatment compared to the WLC, F = 12.51 (115.61), p = .001, with a 
significant effect for time, F = 81.74 (115.61), p <.001. Comparison between CBT-SAD and 
CBT-GEN from baseline to 12-weeks showed no significant differences between treatments 
in change over time, but a significant overall improvement for treatment in general, F = 
149.95 (88.54), p <.001. From baseline to 6-month follow-up there was a significant time 
effect indicative of improvements in global functioning for those who received treatment, F = 
224.27 (86.88), p <.001, but no significant differences between CBT-SAD and CBT-GEN 
over time. 
2.4. Secondary outcome measures 
 From pre- to 12-weeks, significantly greater improvements were found for those 
receiving treatment compared to the WLC on the SPAI-C, F = 4.54 (99.47), p =.036, SPAI-P, 
F = 8.50  (102.61), p = .004, SCAS-C, F = 8.60 (98.35), p =.004, and SCAS-P, F = 12.18 
(100.48), p =.001.  
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Significant overall effects for time were evident on the SPAI-C, F = 21.56 (99.47), p 
<.001, SPAI-P, F = 26.66 (102.67), p <.001, SCAS-C, F = 25.64 (98.35), p <.001, and SCAS-
P, F = 41.53 (100.48), p <.001. Overall group effects were significant for the SPAI-P, F = 
5.17 (102.67), p =.025, and SCAS-P, F = 4.24 (121.60), p =.041.  
 When CBT-SAD and CBT-GEN treatments were compared from baseline to 12-
weeks, significant overall improvements were evident for treatment in general on the SPAI-C, 
F = 38.50 (76.19), p <.001, SPAI-P, F = 55.87 (79.42), p <.001, SCAS-C, F = 60.45 (76.96), 
p <.001, and SCAS-P, F = 90.47 (76.43), p <.001. However, there was no significant 
difference between CBT-SAD and CBT-GEN in terms of change over time on any measure.  
 When CBT-SAD and CBT-GEN were compared from baseline to 6-month follow-up, 
again there were substantial time effects indicative of significant improvements for those who 
received treatment on the SPAI-C, F = 60.12 (62.78), p <.001, SPAI-P, F = 85.32 (76.69), p 
<.001, and SCAS-C, F = 74.19 (66.44), p <.001, SCAS-P, F = 126.91 (63.88), p <.001, but no 
significant difference between CBT-SAD and CBT-GEN over time on any clinical outcome 
measure.  
 In terms of clinical improvement on the Clinical Global Impression – Improvement 
Scale, at 12-weeks, those receiving treatment showed significantly greater levels of 
improvement than the WLC,  χ2 (4) = 11.66, p = .02, with no significant difference between 
CBT-SAD and CBT-GEN. Of the 94 participants who received either CBT-SAD or CBT-
GEN treatment, 5 (5.3%) were assessed as very much improved, 26 (27.9%) as much 
improved, 37 (39.4%) as improved but minimally, 26 (27.9%) as not changed, and 1 (1.1%) 
as minimally worse at 12-weeks. Of the 30 WLC participants, 1 (3.3%) was very much 
improved, 3 (10%) were much improved, 8 (26%) were minimally improved, 16 (53.3%) 
were not changed, and 2 (6.7%) were minimally worse at 12-weeks. From baseline to 6-
month follow-up, there was no significant difference between CBT-SAD and CBT-GEN in 
terms of clinical improvement on the CGI-IS. Of the 61 participants who received either 
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CBT-SAD or CBT-GEN treatment and completed the 6-month ADIS-C/P interview, 21 
(34.4%) were assessed as very much improved, 21 (34.4%) as much improved, 15 (24.6) as 
improved but minimally (39.4%), 3 (4.9%) as not changed, and 1 (1.6%) as minimally worse. 
2.5. Cognitive and behavioral measures 
 In terms of post-event processing, from baseline to 12-weeks, those receiving 
treatment showed significantly greater reductions in PEP than the WLC, F = 3.92 (99.44), p 
=.05, with an overall effect for time, F = 5.32 (99.47), p =.023, and condition (treatment vs 
WLC), F = 4.94 (119.94), p =.028. For social skills, there was an overall effect for time on the 
SSQ-C, F = 10.47, (106.57), p =.001 and SSQ-P, F = 34.06 (106.03), p <.001, but no 
significant treatment or treatment by time effects suggesting a tendency for participants in 
general to improve their social skills over time, irrespective of whether they received 
treatment.  
 From baseline to 6-month follow-up there were significant overall effects for time, 
indicative of improvements for those who received treatment, on measures of PEP, F = 36.74 
(61.17), p <.001, and social skills, SSQ-C, F = 25.35 (78.01), p =.001; SSQ-P, F = 69.04 
(64.99), p <.001. However, there were no significant differences between CBT-GEN and 
CBT-SAD in change over time for SSQ-C or PEPQ-R, although for the SSQ-P this effect 
approached significance, F = 3.90 (64.99), p =.05, with CBT-SAD showing greater 
improvement in social skills than CBT-GEN.  
2.6. Association between changes social skills, PEP, and reductions in anxiety 
 It was initially predicted that CBT-SAD would show significantly greater 
improvements in PEP and social skills than CBT-GEN and that improvements in these factors 
would mediate reductions in anxiety from baseline to 12-weeks. Given that the two treatments 
did not differ significantly from each other on PEP, and yet showed significantly greater 
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improvements on this measure than the WLC, we combined data from the two treatments in 
order to examine this potential mechanism of change. Separate analyses were conducted to 
determine the indirect effects upon residual change on the CSR, SPAI-P, SPAI-C, SCAS-P 
and SCAS-C.  
 In terms of correlations, reductions in PEPQ-R from baseline to 12-weeks correlated 
significantly with reductions on the SCAS-C (r = .43, p<.001), SCAS-P (r = .24, p=.04), and 
SPAI-C (r = .53, p<.001) but not on the SPAI-P or CSR. There were also significant 
correlations between changes in social skills and changes in some outcome variables, with 
improvements on the SSQ-P being significantly associated with reductions in CSR (r = -.25, 
p=.015), SCAS-P (r = .44, p<.001), and SPAI-P (r = -.53, p<.001). Improvements in child 
rated social skills on the SSQ-C were significantly associated with reductions on SPAI-C (r = 
-.27, p=.015) and CSR (r = .-.38, p<.001). 
The tests of cross-sectional mediation revealed that for the SPAI-C, the effect of 
treatment on change in PEPQ-R (path a) was statistically significant (B = -.44, SE = .19, t = -
2.30, p = .024) and the effect of change in PEPQ-R upon change in SPAI-C (path b) was also 
significant (B = .47, SE = .08, t = 5.59, p < .001). The indirect effect of treatment upon 
change in SPAI-C via change in PEP (ab) was statistically significant (Coeff = -.21, SE = .11, 
95% CI -.46: -.03). The proportion of variance in intra-individual change in social anxiety on 
the SPAI-C explained by the indirect effect through PEP was 61%.  This result is consistent 
with cross-sectional mediation in which treatment has its effect upon SPAI-C through its 
influence on PEP.  
Similar results were found for youth reported anxiety on the SCAS-C. A significant 
association was found between treatment and changes in PEPQ-R (a path: B = -.57, SE = .20, 
t = -2.91, p < .001) and between changes in PEPQ-R and changes on SCAS-C (b path: B = 
5.02, SE = 1.35, t = 3.73, p < .001). There was also a significant indirect effect (ab) in 
explaining the effect of treatment upon reductions in anxiety on the SCAS-C,  (Coeff = -2.86, 
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SE = 1.30, 95% CI -6.40: -.87). The indirect effect explained 53% of the total effect of 
treatment upon changes in anxiety on the SCAS-C. This finding is consistent with the view 
that treatment has its effect upon anxiety symptoms through its impact on PEP. There was no 
evidence that pre- to 12-week changes in PEPQ-R mediated changes on the CSR, SPAI-P or 
SCAS-P over this period. There were no significant mediation effects for changes in parent or 
youth reported social skills and any of the outcome variables.  
Given that the mediational analyses were cross-sectional, it was important to determine 
whether the signficant mediational effects could simply reflect correlations between PEP and 
anxiety symptoms. Thus, the analyses were reversed to examine changes in anxiety as a 
mediator of PEP in response to treatment. A similar pattern of results was evident, when the 
analyses were reversed, with significant indirect effects of changes in anxiety (both SCAS-C 
and SPAI-C) on the association between treatment and changes in PEP. The implications of 
this finding are discussed below. 
2.7. Completion of therapy sessions 
The number of therapy sessions completed was compared between child and adolescent 
participants (and their parents), as well as between participants receiving CBT-GEN and those 
allocated to CBT-SAD. Program compliance was conceptualized as the proportion of program 
sessions completed, given that the adolescent parent program contains fewer therapy sessions 
(five) than the child parent program (six sessions).  
The average number of sessions completed by child participants at 12-weeks was 4.75 
out of 10 sessions (47.46%), and 4.32 out of 6 (72.03%) for their parents. Adolescent 
participants completed on average 4.0 out of 10 sessions (40%) while their parents completed 
on average 3.18 out of 5 sessions (63.64%). Participants continued to complete sessions after 
the 12-week assessment, such that by 6-month follow–up, children had completed an average 
of 6.57 (65.74%) of core sessions, and adolescents had completed an average of 4.88 (48.8%) 
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of core sessions. By 6-month follow-up, parents of children had completed an average of 4.77 
(79.51%) of core sessions, and parents of teens had completed an average of 3.50 (70%) of 
core sessions. There were no significant differences between the completion of therapy 
sessions by children or parents in the CBT-GEN versus CBT-SAD conditions. Only 21% of 
young people and 26% of parents completed at least one booster session.  
2.8. Association between completion of therapy sessions and outcome 
 We examined whether the proportion of core therapy sessions completed by young 
people was associated with treatment outcome at 6-month follow-up, using linear regression 
analyses, controlling for baseline level of the measure, gender, type of treatment (CBT-SAD 
or CBT-GEN) and age level or program (Child or Teen). Analyses indicated that a greater 
number of completed therapy sessions by 6-months (but not by 12-weeks) was significantly 
associated with greater clinical improvement as measured by the CSR, (B= -.04, p=.01), 
SPAI-C (B= -.20, p=.05) and CGAS (B= .14, p=.03), but not for the SCAS-C, SCAS-P or 
SPAI-P. Further investigation indicated significant effects for the interaction between session 
completion and age level (child or teen) in the prediction of changes in CSR, SPAI-C and 
CGAS. Posthoc analyses showed that greater session completion was associated with stronger 
reductions in anxiety and improvements in functioning for children but not adolescents.  
2.9. Treatment Satisfaction Questionnaire – Child and Parent Version. 
 There were no significant differences between CBT-SAD and CBT-GEN in terms of 
treatment satisfaction ratings at 12-weeks, for either parents or youth. Youth ratings showed a 
mean of 3.28 (SD=1.05) and 3.02 (SD=.87) for CBT-SAD and CBT-GEN respectively, with 
mean parent ratings of 3.24 (SD=.73) and 3.21 (SD = .72). These ratings are indicative of 
moderate satisfaction with the programs.  
 
3. Discussion 
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3.1.  Overall impact of intervention and comparison between treatments 
 The results of the present study did not support the proposition that an intervention 
that included social skills training, components to reduce self-focused attention, and more in-
depth restructuring of maladaptive cognitions related to social interactions, would be produce 
significantly better outcomes than traditional CBT in the treatment of SAD in children and 
adolescents. No significant difference in outcome was evident between the two interventions 
after 12-weeks. Nevertheless, CBT intervention in general was associated with significantly 
greater clinical improvements compared to the WLC on youth and parent report 
questionnaires and independent clinician ratings of severity, improvement and global 
functioning at 12-weeks. These improvements were sustained or further enhanced for the two 
treatment conditions during the 6-month follow-up period for those who received treatment, 
but again with no significant difference in outcome between treatments. 
Despite substantial reductions in social anxiety symptoms and improvements in 
functioning at 12-weeks, with continued improvements by 6-month follow-up, the impact on 
the clinical diagnosis of SAD was weak. Only 12.8% of CBT-SAD and 14.6% of CBT-GEN 
participants in the ITT sample were free of their SAD diagnosis at 12-weeks, and 29.8% and 
35.4% respectively at 6-month follow-up.  This finding is consistent with the results of 
Hudson, Rapee, et al. (2015), in which 22.3% and 30.7% of those with a primary diagnosis of 
SAD were free of this diagnosis after treatment and at follow-up respectively following 
traditional, clinic-based CBT for anxiety disorders. In the present study, the results were more 
positive for those cases in which the child or parent had completed at least 3 core treatment 
sessions and provided evaluation data, with 51.9% of CBT-SAD and 47.1% of CBT-GEN 
being free of their SAD diagnosis at 6-month follow-up.   
It is important to examine possible explanations for the failure to find significantly better 
outcomes from the tailored CBT-SAD intervention compared to the generic approach, and 
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also to explain the weak impact of both treatments upon clinical diagnoses despite significant 
reductions in SAD severity and improvements in functioning. 
3.2. Possible explanations for low impact of treatment upon diagnosis despite 
improvements in symptoms and global functioning 
 In terms of explanations for the weak impact of both treatments upon the clinical 
diagnosis of SAD, we note that the sample showed extremely high levels of social anxiety 
upon admission to the study. Indeed, the mean CSR value was around 7 on the 8-point scale 
(indicative of extremely high severity and impairment). This CSR is higher than most other 
studies examining the treatment of youth SAD, where mean baseline CSRs have typically 
been between 5 and 6 (e.g. Beidel et al., 2000; Garcia-Lopez et al., 2014; Spence et al., 2000). 
There was also a very high degree of comorbidity, with participants having on average 2.86 
diagnoses and 79.9% of participants showing at least one further anxiety disorder, and 14 
participants meeting criteria for Selective Mutism. Mean baseline CGAS ratings 
approximating 45 at baseline also suggested a moderate to severe level of functional 
impairment. Thus, the failure to eliminate diagnoses despite marked and significant 
improvements in social anxiety and global functioning could partly reflect the extremely high 
initial severity. To reach an end state in which there is no clinical diagnosis may require a 
treatment that is longer in terms of number of sessions.  
Kerns et al. (2013) reached a similar conclusion in relation to clinic-based treatment of 
youth SAD and proposed that longer and more intensive treatments may be needed. These 
authors found that anxious young people with elevated SAD symptoms or a SAD diagnosis in 
their profile were significantly less likely to be free of their primary clinical diagnosis after 
treatment compared to youth without a SAD diagnosis following clinic-based CBT. They 
concluded that, despite equivalent decreases in anxiety severity during treatment, a lower 
proportion of youth with social anxiety symptoms or diagnoses fell below diagnostic criteria 
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after treatment because their initial presentation was more severe. They also noted that youth 
with SAD symptoms were more likely to show a resurgence of anxiety during long-term 
follow-up. Hudson, Rapee, et al. (2015), in discussion of clinic-based CBT for youth with 
SAD also proposed the need for longer intervention given the long-standing issues of 
behavioral inhibition that may youth with SAD have experienced. They suggest that this long-
standing trait may make SAD more resistant to change. In particular, they proposed the need 
for more sessions that include intensive, invivo exposure and practice of cognitive and 
behavioral skills, and strategies to ensure reduction in the use of safety behaviors. 
It is also possible that outcomes would be stronger, resulting in a greater level of change 
and loss of a clinical diagnosis of SAD, if the intervention involved face-to-face treatment 
rather than internet-completed sessions. Although our prior research has demonstrated 
equivalent outcomes for internet-delivered CBT with minimal therapist assistance compared 
to the same program delivered using the internet (Spence et al., 2011), that study was 
conducted with varying types of anxiety disorder, and baseline indicators of severity were less 
severe, with CSR (Mean = 6) and CGAS (Mean = 50).  With severe cases of SAD, clinic-
based delivery may have advantages such as having greater control over the rate of 
completion of sessions, the ability to tackle treatment and non-treatment related difficulties 
that could trigger drop-out from therapy, and greater opportunities to engage in exposure tasks 
invivo in a group-therapy context.  
In the present study, participants tended to work their way more slowly through the 
sessions than may be the case with clinic-delivery. At the 12-week point many participants 
had not completed their sessions, with youth in both CBT-GEN and CBT-SAD having 
completed on average only 4 of the 10 sessions at 12-weeks. However, they continued to 
complete sessions during the follow-up period, so that by 6-month follow-up they had 
completed an average of 6.6 of the 10 core sessions. While all core treatment strategies were 
covered in the first 6 sessions, very few participants progressed to complete the final two 
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sessions in which all the previously learned material is brought together and instructions are 
provided for further practice. Thus, the slow rate of session completion and failure of some 
participants to complete all 10 sessions may have limited the strength of treatment outcomes. 
Clinic-delivered treatments tend to have more control over the rate of session completion and 
may also have a greater influence over session completion. We note, however, that in a study 
involving a range of types of anxiety disorders, Spence et al. (2011) did not find a difference 
in the number of sessions completed between clinic and internet program delivery, although 
youth in the internet delivery condition completed a higher number of sessions at 12-weeks 
(Mean=7.5 out of 10) than was found in the present study.  
Another possible limitation of the internet-delivery modality in the present study is that, 
despite detailed computer-based information, interactive tasks and online therapist guidance, 
socially anxious children and adolescents may find it particularly difficult to complete the 
practice sessions outside the sessions. Without strong face-to-face therapist guidance and 
support, they may avoid practicing the skills they have learned in the sessions, and may avoid 
implementing their fear hierarchy. This proposition is consist with the finding that, for the 
younger age group at least, greater session compliance by follow-up was associated with 
better treatment outcomes for both treatments.  While online therapy may seem appealing to 
young people with SAD because it can be completed without requiring feared face-to-face 
interactions within treatment sessions, they are missing out on potentially important exposure 
experiences that they would have during face-to-face sessions, particularly in a group context. 
Future online interventions for SAD in young people need to identify ways of increasing 
opportunities for practicing skills outside sessions, and increasing program engagement and 
session compliance.  
3.3. Possible explanations for the lack of difference between treatments 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
It is also important to discuss possible reasons for why the CBT-SAD intervention did not 
enhance outcomes over and above CBT-GEN in line with hypotheses. Authors such as 
Hudson, Rapee, et al. (2015) and Spence and Rapee (2016) have made a strong case for the 
inclusion of social skills training, and techniques to reduce self-focused attention, and 
maladaptive cognitive processes before, during and after feared social interactions. In terms of 
social skills, all three conditions, including the WLC showed equivalent improvements in 
social skills by 12-weeks. At 6-month follow-up, there was a trend for CBT-SAD to show 
greater improvements in social skills according to parent (p=.05), but not youth, report. Thus, 
although there was a trend, we cannot say conclusively that the CBT-SAD intervention was 
effective in enhancing social skills. Again, it is possible that internet treatment delivery may 
not be the best method for social skills training in socially anxious youth. Although the 
content included videotaped exemplars and interactive online exercises to teach social skills, 
with home tasks to practice the use of social skills outside the session, the internet mode of 
delivery did not provide the opportunity to practice skills with other young people within the 
therapy sessions and to receive feedback about performance, as is the case with group-based 
clinic therapy. Potentially, a combination of face-to-face, group-based intervention, 
supplemented with online examples could produce better results. The Beidel et al. (2000) 
clinic-based program described above, for the treatment of SAD in youth, provides extensive 
opportunity for skills practice within and between sessions and has shown positive outcomes 
with 67% of participants no longer meeting diagnostic criteria for social phobia at post-
treatment. Although this result is encouraging, there is still room for improvement. The Beidel 
et al. program does not include an intensive focus on changing the maladaptive cognitive 
processes associated with SAD, and in the present paper we suggested that outcomes for the 
treatment of youth SAD would be greater if the intervention included both social skills 
training and cognitive change strategies. 
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 The results of the present study also did not find that CBT-SAD was more effective in 
changing maladaptive cognitive processing (at least as measured by PEP) than CBT-GEN. 
Both interventions were associated with significantly greater reductions in PEP than the WLC 
at 12-weeks, but with no significant difference between treatments.  It appears therefore that 
the cognitive change strategies included in CBT-GEN were sufficient to produce significant 
reductions in PEP despite a more detailed and intensive focus in CBT-SAD on changing 
maladaptive cognitions associated with feared social situations. The generic approach may be 
sufficient for bringing about reductions in PEP, and it is feasible that participants in CBT-
GEN were able to generalize sufficiently from the generic content to their own situation. 
However, the data were consistent with the view that changes in PEP may be an 
important mechanism through which reductions in social anxiety occur, with changes in PEP 
being associated with changes in social anxiety in response to treatment. We acknowledge 
that, while the cross-sectional findings were consistent with mediation by PEP, we are unable 
to draw firm conclusions about causality given that we could not test longitudinal mediation. 
As the analysis was cross-sectional, we cannot exclude the possibility that PEP is purely a 
reflection of SAD rather than being a mediating variable, or that there may be a reciprocal 
relationship between changes in social anxiety and changes in PEP. Nevertheless, the finding 
that changes in PEP are associated with reductions in social anxiety in response to treatment is 
consistent with research in the adult literature (McEvoy et al., 2009)(Hedman et al., 2013).  
The CBT-SAD intervention also included a significant emphasis on reducing self-focused 
attention, in keeping with the recommendations of Hudson et al., (2015). However, we did not 
include a measure of this construct in order to determine whether it did indeed change in 
response to CBT-SAD. Future studies should include the monitoring of self-focused attention 
to ensure that changes are occurring and to determine its potential role as a mediator of 
treatment outcome.  
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Although the CBT-SAD intervention included elements to address the cognitive 
distortions and biases associated with SAD, it is possible that these efforts need to be even 
more intensive. Hudson, Rapee, et al. (2015) noted that it may be harder to achieve 
disconfirmation of fear expectancies in social situations, compared to other types of feared 
situations. They suggest that, after social interactions, it can be ambiguous to the young 
person as to whether the outcome is positive or negative, and thus negative interpretation 
biases may persist. Thus, treatment may need to include strategies that specifically aim to 
disconfirm maladaptive social beliefs and interpretations.  
There may also be other ways to strengthen the content of CBT-SAD. For example, 
the current intervention did not include a focus on imagery in relation to changing PEP. Given 
that post-event imagery has been shown to be a significant predictor of social anxiety in 
youth, (Ranta et al., 2014), it may be possible to use techniques such as imagery rescripting to 
reduce the frequency of distressing imagery associated with prior social experiences in young 
people (Norton & Abbott, 2016). 
3.4. Limitations and future directions 
Although the present study has many strengths, there are several methodological 
limitations that need to be noted. For example, there was a relatively high drop-out rate in 
terms of participants who failed to complete outcome interviews and questionnaires.  Given 
that the analyses were conducted on an intent-to-treat basis, the findings may provide a 
conservative estimate of treatment effectiveness. Furthermore, the relatively slow rate of 
session completion meant that, at the 12-week assessment point, many families had not 
completed the majority of sessions. Thus, comparison with the WLC at this point may not 
have provided a valid indicator of the strength of the treatment. Indeed, for those who had 
completed at least 3 core treatment sessions (parent or child) and who completed the 
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evaluations, the percent free of their SAD diagnosis at 6-months was similar to results 
reported from clinic-based studies. 
The sample size of 125, while providing sufficient power to detect differences 
between active intervention and WLC, was weak when it came to detecting potential 
differences between the two active clinical conditions. The initial intent was for a much larger 
sample size (300) but we had difficulty recruiting a sufficient number of participants who met 
all inclusion criteria within the timeframe of the study which had been delayed by longer than 
anticipated time to develop the CBT-SAD online program. We note, however, that there were 
no clear trends for superiority of either treatment approach.  
A further limitation in the present study was the lack of data from the WLC at follow-
up, which restricted our ability to examine mediating variables. Future research should 
include more frequent assessment of both outcome and potential mediating variables to enable 
examination of longitudinal mediation.  
Finally, as noted above, the current study did not provide convincing evidence that 
CBT-SAD produced significantly greater reductions in PEP and improvements in social skills 
than CBT-GEN.  This means that we cannot draw firm conclusions as to whether an 
intervention that changes underlying cognitive and behavioral factors associated with SAD is 
more effective than a generic approach. A true test requires demonstration that a) CBT-SAD 
is more effective than CBT-GEN in changing these cognitive and behavioral factors, b) CBT-
SAD is more effective than CBT-GEN in reducing social anxiety, and c) changes in the 
targeted cognitive and behavioral variables mediate changes in social anxiety.  
A key challenge in future research will be to identify ways of increasing treatment 
compliance among young people who complete intervention, particularly if this is delivered 
using the internet. Furthermore, when delivered through the clinic or the internet there 
remains a significant need to identify ways of increasing treatment outcomes for young people 
with SAD. For example, methods such as virtual reality could be used to provide realistic 
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opportunities to practice social skills and exposure tasks, with therapists being able to provide 
live feedback. This may also be a method through which young people could learn to 
challenge some of the biased cognitions and beliefs before, during and after feared social 
interactions. Future research should also examine the impact of comorbidity upon the 
treatment of SAD in order to identify treatments that are most likely to be beneficial with 
children with different profiles of comorbidity. For example, a CBT-GEN approach may be 
more appropriate for young people with a high level of comorbid symptoms in addition to 
SAD, whereas this may not be the case for youth with only SAD. It would also be valuable to 
examine whether the presence of poor social skills, or specific cognitive factors such as PEP 
or self-focused attention, influence treatment outcome and whether treatments can be tailored 
to the needs of particular clients in order to optimize treatment outcomes.  
4. Conclusion  
Both CBT-SAD and CBT-GEN were associated with significant reductions in social 
anxiety symptoms and improvements in global function over time for children and 
adolescents with SAD. These improvements were significantly greater than any changes 
evident for the WLC at 12-weeks, and were maintained at 6-month follow-up. Contrary to 
hypotheses, there were no significant differences in outcome between CBT-SAD and CBT-
GEN. Furthermore, CBT-SAD did not result in significantly greater changes in PEP than 
CBT-GEN, although there was a trend for CBT-SAD to show greater improvements in parent 
rated social skills at follow-up. Despite substantial and significant reductions in social anxiety 
symptoms and improvements in global functioning, the majority of participants continued to 
show a diagnosis of SAD after treatment. Possible explanations for this finding are discussed, 
particularly the extremely high initial clinical severity of SAD in the sample. Given the 
considerable distress, interference and adverse consequences of SAD, its persistence if left 
untreated, and its relative resistance to current treatment methods, it is important that 
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researchers and clinicians continue to seek and evaluate methods to enhance the treatment 
effectiveness for SAD in children and adolescents.  
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Table 1 
Sociodemographic details for participants 
 
Note: Values represent number of participants (percentages) or means ± SD, as appropriate. CSR = Clinician 
Severity Rating; CGAS = Children’s Global Assessment Scale; DX = diagnosis; GAD = Generalized Anxiety 
Disorder; Enur = Enuresis; Pan = Panic Disorder; Agor = agoraphobia; ODD = Oppositional Defiant Disorder; 
OCD = Obsessive Compulsive Disorder. 
 
 
  
 
Total 
(N = 125) 
WLC 
(n = 30) 
CBT-GEN 
(n = 48)   
CBT-SAD 
(n = 47) 
Age in Years (SD) 11.29 (2.67) 11.6 (2.72) 11.02 (2.57) 11.34 (2.78) 
   Range (years) 8–17 8-16 8-17 8-17 
Female N(%) 75 (60) 16 (53.3) 26 (54.2) 33 (70.2) 
Country of Birth     
     Australia 104 (83.3) 26 (86.7) 41 (85.4) 37 (78.7) 
     USA/Canada 6 (5.6) 1 2 3 
     United Kingdom 5 (4.0) 1 1 3 
     New Zealand 3 (2.4) 1 0 2 
     Europe 2 (1.6) 1 0 1 
     Africa 2 (1.6) 0 2 0 
     Asia 1 (0.8) 0 0 1 
    Other/Missing 2 0 2 0 
Indigenous Australian 3 (2.4) 0 2 (4.2) 1 (2.1) 
Living Arrangements     
     Both biological parents 106 (84.9) 27 (90) 39 (81.3) 40 (85.1) 
SES (n = 119) (SD)     
      High (> AUS$100 001)             69 (54.8) 14 (46.7) 28 (58.3) 27 (57.4) 
      Low+Middle (<100,000k) 50 (40.5) 16 (53.0) 18 (37.5) 17 (36.2) 
Program Age Group     
      Child 79 18 (60) 30 (62.5) 31 (66) 
      Teen 46 12 (40) 18 (37.5) 16 (34) 
CSR (Primary DX:SAD) 6.85 (0.97) 6.73 (0.8) 6.77 (1.1) 7 (1.0) 
CGAS 46.03 (6.83)  46.53 (6.08) 46.69 (7.47) 45.04 (6.6) 
Secondary Diagnosis     
     None 27 (21.6) 5 (16.7) 16 (33.3) 6 (12.8) 
     Selective mutism 14 (11.2) 3 (10.0) 6 (12.5) 5 (10.6) 
     GAD 44 (28.9) 8 (26.7) 14 (29.2) 22 (46.8) 
     Separation Disorder 10 (6.6) 2 (6.7) 4 (8.3) 4 (8.5) 
     Specific Phobia 21 (13.8) 8 (26.7) 8 (16.8) 5 (10.6) 
     Dysthymia 6 (3.9) 3 (10.0) 0 3 (6.4) 
     Other Enur/pan/agor/ODD/OCD 3 (2.0) 1 (3.3) 0 2 (2.2) 
Tertiary Diagnosis     
     None 54 12 (40) 23 (47.9) 19 (40.4) 
     GAD 26 8 (26.7) 4 (8.3) 14 (29.8) 
     Separation Disorder 13 7 (23.3) 1 (2.1) 5 (10.6) 
     Specific Phobia 22 2 (6.6) 15 (31.3) 5 (10.6) 
     Dysthymia 3 1 (3.3) 0 2 (4.3) 
     Other Enur/pan/agor/ODD/OCD 7 0 5 (10.5) 2 (4.2) 
Number of anxiety DXs 2.86 (1.56) 2.73 (1.14) 2.90 (1.98) 2.89 (1.32) 
Total number of DXs 3.03 (1.70) 2.93 (1.39) 3.00 (2.07) 3.13 (1.48) 
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Table 2.  
Diagnostic Outcome Measures at Each Assessment Point  
 CBT-SAD CBT-GEN WLC 
Percent free of primary anxiety diagnosis    
12-week assessment    
ITT sample 6/47 (12.8%) 7/48 (14.6%) 1/30 (3.3%) 
Retained sample 6/35 (17.1%) 7/34 (20.6%) 1/27 (3.7%) 
6-month follow-up    
ITT sample 14/47 (29.8%) 17/48 (35.4%)  
Retained sample 14/27 (51.9%) 16/34 (47.1%)  
Percent free of any anxiety diagnosis    
12-week assessment    
ITT sample 2/47 (4.3%) 7/48 (14.6%) 0/30 (0%) 
Retained sample 2/35 (5.7%) 7/34 (20.6%) 0/27 (0%) 
6-month follow-up    
ITT sample 10/47 (21.3%) 16/48 (33.3%)  
Retained sample 10/27 (37.0%) 15/34 (44.1%)  
    
Note. Retained sample included participants with data available at the 12-week assessment time point. 
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Table 3 
Estimated Marginal Means and Standard Errors for Continuous Variables from Baseline to 
12-week Assessment 
 
Note. CSR = Clinician Severity Rating; CGAS = Children’s Global Assessment Scale; SPAI-C/P = 
Social Phobia and Anxiety Inventory - Child/Parent ; SCAS-C/P = Spence Children’s Anxiety 
Scale - Child/Parent; SSQ-C/P= Social Skills Questionnaire- Child/Parent; PEPQ-R = Post Event 
Processing Questionnaire- Revised 
 
 
 
  
Condition CBT-SAD CBT-GEN WLC 
Measure Time M SE  M SE  M SE  
CSR Baseline 7.00 0.24  6.77 0.23  6.73 0.30  
 12-wks 4.72 0.26  4.53 0.25  5.95 0.31  
CGAS Baseline 45.04 1.18  46.69 1.17  46.53 1.48  
 12-wks 55.83 1.29  58.12 1.24  51.41 1.54  
SPAI-C Baseline 29.02 1.78  27.92 1.79  26.64 2.23  
 12-wks 21.81 1.97  19.19 1.94  23.68 2.39  
SPAI-P Baseline 37.79 1.56  34.89 1.57  37.56 1.98  
 12-wks 29.47 1.78  24.10 1.78  34.90 2.06  
SCAS-C Baseline 42.18 2.40  33.50 2.39  35.75 3.10  
 12-wks 29.51 2.59  22.87 2.56  32.62 3.10  
SCAS-P Baseline 34.87 1.93  29.23 1.87  32.62 2.33  
 12-wks 21.14 2.07  17.16 1.99  28.81 2.51  
SSQ-C Baseline 41.84 1.12  44.33 1.11  42.67 1.38  
 12-wks 46.57 1.24  46.26 1.30  45.33 1.49  
SSQ-P Baseline 35.75 1.58  40.77 1.56  34.90 1.97  
 12-wks 43.53 1.76  45.72 1.69  41.45 2.04  
PEPQ-R Baseline 383.04 32.41  351.63 31.81  408.45 40.92  
 12-wks 287.87 36.17  216.40 37.98  399.13 44.87  
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Table 4 
Estimated Marginal Means and Standard Errors from Baseline to 12-week Assessment and 
6- Follow-up for CBT-SAD and CBT-GEN  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. CSR = Clinician Severity Rating; CGAS = Children’s Global Assessment Scale; SPAI-C/P = Social Phobia 
and Anxiety Inventory for Children- Child/Parent ; SCAS-C/P = Spence Children’s Anxiety Scale - 
Child/Parent; SSQ-C/P= Social Skills Questionnaire- Child/Parent; PEPQ-R = Post Event Processing 
Questionnaire- Revised 
 
 
 
 
  
Condition CBT-SAD CBT-GEN 
Measure Time M SE  M SE  
CSR Baseline 7.00 0.30  6.77 0.30  
 12-wks 4.72 0.33  4.54 0.32  
 6-mth fup 2.99 0.37  2.87 0.33  
CGAS Baseline 45.04 1.39  46.69 1.38  
 12-wks 55.74 1.52  58.07 1.46  
 6-mth fup 62.62 1.67  65.34 1.49  
SPAI-C Baseline 29.02 1.70  27.89 1.71  
 12-wks 21.80 1.90  19.29 1.87  
 6-mth fup 16.25 2.22  16.36 2.08  
SPAI-P Baseline 37.79 1.60  34.81 1.62  
 12-wks 29.06 1.84  24.10 1.83  
 6-mth fup 24.24 2.15  20.04 1.83  
SCAS-C Baseline 42.17 2.10  33.48 2.09  
 12-wks 29.09 2.31  23.27 2.28  
 6-mth fup 22.95 2.66  20.03 2.44  
SCAS-P Baseline 34.75 1.82  29.20 1.76  
 12-wks 21.23 1.95  17.23 1.87  
 6-mth fup 17.74 2.22  13.54 1.95  
SSQ-C Baseline 41.87 1.14  44.12 1.13  
 12-wks 46.56 1.27  46.01 1.33  
 6-mth fup 48.70 1.58  48.67 1.43  
SSQ-P Baseline 35.75 1.45  40.77 1.43  
 12-wks 43.58 1.59  45.62 1.53  
 6-mth fup 46.87 1.78  47.93 1.60  
PEPQ-R Baseline 383.47 30.12  351.63 29.54  
 12-wks 288.83 34.04  213.85 35.84  
 6-mth fup 178.70 44.53  159.84 40.85  
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Table 5 
Mixed Model Effects Comparing (i) Treatment vs WLC and (ii) CBT-SAD vs CBT-GEN From Baseline to 12-week Assessment for CSR, CGAS and 
SPAI-C/P for ITT Analysis 
 CSR CGAS SPAI-C  SPAI-P  
 B 
(SE) 
t 
 (CIs) 
d B 
(SE) 
t 
 (CIs) 
d B 
(SE) 
t 
(CIs) 
d B 
(SE) 
t 
(CIs) 
d 
(i) Treatment vs WLC             
Intercept at Pre-             
     WLC  6.73 
(.30) 
22.72*** 
(6.15 - 7.32) 
 46.53 
(1.48) 
31.34*** 
(43.60 – 49.46) 
 26.63 
(2.24) 
11.90 
(22.21–31.05) 
 37.55 
(2.00) 
18.77*** 
(33.61- 41.50) 
 
      WLC vs Treatment 0.15 
(.34) 
.44 
(-.52 - .82) 
 -.66 
(1.70) 
-.39 
(-4.01 – 2.70) 
 1.82 
(2.57) 
.71 
(.71 - .48) 
 -1.22 
(2.29) 
-.53 
(-5.74- 3.30) 
  
Slope Pre- to 12 wks               
     WLC  -.78 
(.34) 
-2.30 
(-1.45 - -.11) 
.48 4.88 
(1.53) 
3.18** 
(1.84 - 7.91) 
.60 -2.96 
(2.02) 
-1.46 
(-6.98 – 1.06) 
.24 -2.66 
(2.01) 
-1.32 
(-6.65 – 1.34) 
.24  
     WLC vs Treatment  -1.48 
(.39) 
-3.77*** 
(-2.26 - -.70) 
.91 6.27 
(1.77) 
3.54*** 
(2.76 – 9.78) 
.77 -5.01 
(2.35) 
-2.13* 
(-9.68 - -.34) 
.41 -6.89 
(2.36) 
-2.92** 
(-11.58 - -2.20) 
.64  
Random Effects              
     Residual variance  1.61   32.46   50.96   53.11    
       Intercept variance  1.02   33.69   99.35   64.09    
(ii) CBT-GEN vs CBT-SAD 
B 
(SE) 
t 
 (CIs) 
d B 
(SE) 
t 
 (CIs) 
d B 
(SE) 
t 
(CIs) 
d B 
(SE) 
t 
(CIs) 
d 
 
Intercept at Pre-              
      CBT-GEN  
 
6.77 
(.25) 
27.19 *** 
(6.27 -7.26)  
46.69 
(1.18) 
39.43*** 
(44.35 – 49.03)  
27.93 
(1.67) 
16.66*** 
(24.61-31.25)  
34.91 
(1.55) 
22.52*** 
(31.84-37.97)   
      CBT-GEN vs CBT-SAD 
 
.23 
(.35) 
.65 
(-2.8 - -1.65)  
-1.64 
(1.68) 
-.98 
(-4.97 – 1.68)  
1.09 
(2.37) 
.46 
(-3.59 – 5.77)  
2.87 
(2.18) 
1.32 
(-1.43 – 7.19)   
Slope Pre to 12 wks               
      CBT-GEN  
 
-2.24  
(.29) 
-7.60*** 
(-2.83- -1.66) 
1.30 
 
11.44  
(1.26) 
9.11*** 
(8.94 – 13.93) 
1.39 
 
-8.80 
(1.83) 
-4.80*** 
(-12.44 - -5.15) 
.77 
 
-10.87 
(1.83) 
-5.93*** 
(-14.52 - -7.22) 
1.03 
  
      CBT-GEN vs CBT-SAD 
 
-.04 
(.42) 
-.08  
(-.88 - .81) 
.02 
 
-.65 
(1.81) 
-.36  
(-4.25 – 2.96) 
.08 
 
1.55 
(2.58) 
.60 
(-3.59 – 6.71) 
.13 
 
2.45 
(2.58) 
.95 
(-2.69 – 7.59) 
.09 
  
Random Effects              
      Residual variance  1.87   33.55   60.35   59.21    
      Intercept variance 1.10   33.74   70.57   51.86    
Note. *p < .05, **p <.01, ***p <.001.  CSR = Clinician Severity Rating; CGAS = Children’s Global Assessment Scale; SPAI-C/P = Social Phobia and Anxiety Inventory for 
Children- Child/Parent.  Effect sizes “d” were calculated as the estimated fixed effect divided by the square root of the sum of the two variance components. 
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Table 6 
Mixed Model Effects for Treatment##  vs WLC and CBT-SAD vs CBT-GEN Comparing Baseline and 12-week Assessment for Anxiety, Social 
Skills and Post-Event Processing for ITT Analysis 
 SCAS-C SCAS-P SSQ-C  SSQ-P   PEPQ-R  
 B 
(SE) 
t 
 (CIs) 
d B 
(SE) 
t 
 (CIs) 
d B 
(SE) 
t 
(CIs) 
d B 
(SE) 
t 
(CIs) 
d B 
(SE) 
t 
(CIs) 
Treatment## vs WLC               
Intercept at Pre-               
     WLC  35.73 
(3.16) 
11.31*** 
(29.49-41.96) 
 32.62 
(2.36) 
13.78*** 
(27.95-37.30) 
 43.10 
(0.80) 
54.01*** 
(41.52-44.67) 
 34.90 
(2.00) 
17.47*** 
(30.95-38-84) 
 408.45 
(41.15) 
9.93*** 
(327-489) 
 
     WLC vs Treatment 2.08 
(3.60) 
.58 
(=5.02 – 9.91) 
 -.76 
(2.73) 
-.25 
(-6.06 – 4.72) 
 -.43  
(1.62) 
-.27 
(-3.62 – 2.75) 
 3.38 
(2.29) 
1.48 
(-1.13 – 7.90) 
 -41.29 
(47.06) 
-.88 
(-134.15- 51.56) 
 
Slope Pre to 12 wks                 
     WLC  -3.11 
(2.52) 
2.53*  
(-8.12 – 1.90) 
.19 -3.82 
(2.23) 
-1.71 
(-8.25 - .61) 
.26 3.35 
(0.96) 
3.51*** 
(1.46 – 5.25) 
.43 6.55 
(1.89) 
3.46** 
(2.80 – 10.29) 
.60 
 
-9.38 
(45.93) 
-.20 
(-100-81.77) 
.04
 
     WLC vs Treatment  -8.55 
(2.92) 
-2.93** 
(-14.34 - -2.76) 
.51 -9.03 
(2.59) 
-3.50*** 
(-14.16- -3.89) 
.70 -.69 
(1.86) 
-.37  
(-4.37 – 3.00) 
.09 -.21 
(2.21) 
-.10 
(-4.59 – 4.16) 
.02 -104.01 
(53.21) 
-1.96# 
(-209.59-1.56) 
.47
Random Effects                
     Residual variance 73.52   62.19   33.42   49.22   25649.6   
     Intercept variance  205.75   105.89   25.91   70.45   23454.9   
CBT-GEN vs CBT-SAD                
Intercept at Pre-                
       CBT-GEN  
 
33.54 
(2.09) 
16.02*** 
(29.41–37.69) 
 29.23 
(1.84) 
15.81*** 
(25.58 – 32.89) 
 44.33 
(1.10) 
40.29*** 
(42.15-46.50) 
 40.77 
(1.42) 
28.67*** 
(37.96-43.58) 
 351.62 
(30.67) 
11.47*** 
(291.02-412.23) 
 
       CBT-GEN vs CBT-SAD 
 
8.66 
(2.97) 
2.92** 
(2.79-14.53) 
 5.65 
(2.66) 
2.12* 
(.39 – 10.91) 
 -2.49 
(1.56) 
-1.60 
(-.87 – 4.72) 
 -5.03 
(2.02) 
-2.49* 
(-9.03- -1.02) 
 32.40 
(43.82) 
.74 
(-54.18 – 118.98) 
 
Slope Pre to 12 wks                 
       CBT-GEN  
 
10.66 
(2.13) 
-4.99*** 
(-14.91- -6.41) 
.74 -12.14 
(1.89) 
-6.41*** 
(-15.91 - -8.37) 
.96 1.92 
(1.41) 
1.37 
(-.87 – 4.72) 
.25 4.94 
(1.40) 
3.53** 
(2.15-7.73) 
.50 -135.90 
(42.04) 
-3.23** 
(-219.55- -52.26)
.64 
      CBT-GEN vs CBT-SAD 
 
-2.20 
(3.02) 
-.73  
(-8.22 – 3.82) 
.15 -1.74 
(2.74) 
.53 
(-7.19 – 3.72) 
.14 2.77 
(1.95) 
1.42 
(-1.10 – 6.66) 
.37 2.85 
(2.02) 
1.40 
(-1.19- 6.89) 
.29 41.04 
(58.45) 
.70 
(-75.29 – 157.37)
.19 
Random Effects                
      Residual variance  80.98   68.84   35.09   38.83   31221.1   
      Intercept variance  123.87   90.52   21.80   58.22   13924.2   
Note. #=.05, *p < .05, **p <.01, ***p <.001.  CSR = Clinician Severity Rating; CGAS = Children’s Global Assessment Scale; SPAI-C/P = Social Phobia and Anxiety Inventory for Children- 
Child/Parent ; SCAS-C/P = Spence Children’s Anxiety Scale - Child/Parent; SSQ-C/P= Social Skills Questionnaire- Child/Parent; PEPQ-R = Post Event Processing Questionnaire- Revised 
 
Note ##  : “Treatment” refers to receipt of CBT-GEN or CBT-SAD
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Table 7 
Mixed Model Effects for CBT-SAD vs CBT-GEN Comparing Baseline and 6-month Follow-up for Anxiety, Social Skills and Post-Event 
Processing for ITT Analysis 
 CSR CGAS SPAI-C  SPAI-P  
 B 
(SE) 
t 
 (CIs) 
d B 
(SE) 
t 
 (CIs) 
d B 
(SE) 
t 
(CIs) 
d B 
(SE) 
t 
(CIs) 
d 
Intercept at Pre-             
       CBT-GEN  
 
6.77 
(.28) 
23.98*** 
(6.21-7.32) 
 46.69 
(1.40) 
33.40*** 
(43.92-49.45) 
 27.87 
(1.15) 
16.32*** 
(24.49-31.25) 
 34.86 
(1.65) 
21.17*** 
(31.60-38.11) 
 
       CBT-GEN vs CBT-SAD 
 
.23 
(.40) 
.57 
(-.56 –1.02) 
 -1.65 
(1.99) 
-.83 
(-5.57-2.28) 
 1.15 
(2.24) 
.48 
(-3.61-5.91) 
 2.93 
(2.32) 
1.26 
(-1.65-7.51) 
  
Slope Pre to 6-mth Fup               
          CBT-GEN  
 
-3.94 
(.37) 
10.62*** 
(-4.67- -
3.20) 
2.0
2 
18.76 
(1.62) 
11.57*** 
(15.53-21.98) 
2.47 -12.01 
(2.22) 
-5.40*** 
(-16.46- -7.56) 
1.03 -14.94 
(2.06) 
-7.25*** 
(-19.04- -10.83) 
1.34  
       CBT-GEN vs CBT-SAD 
 
-.17 
(.56) 
-.32 
(-1.28 - .92) 
.09 -.88 
(2.45) 
-.36 
(-5.74-3.98) 
.12 -1.20 
(3.25) 
.71 
(-7.70-5.30) 
.10 .64 
(3.16) 
.20 
(-5.65-6.95) 
.06  
Random Effects              
      Residual variance  2.83   53.04   68.88   75.71    
        Intercept variance  .99   4.77   65.90   49.37    
 SCAS-C SCAS-P SSQ-C  SSQ-P   PEPQ-R  
 B 
(SE) 
t 
 (CIs) 
d B 
(SE) 
t 
 (CIs) 
d B 
(SE) 
t 
(CIs) 
d B 
(SE) 
t 
(CIs) 
d B 
(SE) 
t 
(CIs) 
d 
Intercept at Pre-                 
       CBT-GEN  
 
33.61 
(2.17) 
15.44*** 
(29.91-37.91) 
 29.20 
(1.88) 
15.56*** 
(25.49- 32.92) 
 44.18 
(1.14) 
38.60*** 
(41.91-46.44) 
 40.77 
(1.45) 
27.98*** 
(-37.88- 43.65) 
 351.62 
(39.67) 
12.67*** 
(296.7- 406.5) 
  
       CBT-GEN vs CBT-SAD 
 
8.62 
(3.07) 
2.80** 
(2.53-14.72) 
 5.56 
(2.70) 
2.06* 
(.22- 10.91) 
 -2.37 
(1.63) 
-1.46 
(-5.59- .84) 
 -5.03 
(2.07) 
-2.43* 
(-9.13- -.92) 
 33.69 
(39.67) 
.40 
(-44.79- 112.17) 
  
Slope Pre to 6-mth Fup                  
       CBT-GEN  
 
-13.91 
(2.64) 
-5.27*** 
(-19.18- -8.63) 
.94 -16.05 
(1.95) 
-8.22*** 
(-19.96- -12.15) 
1.25 4.62 
(1.66) 
2.78** 
(1.31- 7.93) 
.59 7.24 
(1.49) 
4.86*** 
(4.25-10.22) 
.72 -181.54 
(45.07) 
-4.03*** 
(-217.8- -91.29) 
.94  
      CBT-GEN vs CBT-SAD 
 
-6.17 
(3.95) 
-1.56 
(-14.05- 1.70) 
.42 -1.96 
(3.02) 
-.65 
(-8.00- 4.08) 
.15 3.24 
(2.48) 
1.31 
(-1.69- 8.17) 
.41 4.51 
(2.28) 
1.97# 
(-.05 -9.08) 
.45 -40.12 
(66.52) 
-.60 
(-173.12- 93.88) 
.21  
Random Effects                 
      Residual variance  106.16   64.32   43.42   38.04   29471.40    
      Intercept variance  113.01   100.29   18.26   63.85   7515.52    
Note. #=.05,*p < .05, **p <.01, ***p <.001.  CSR = Clinician Severity Rating; CGAS = Children’s Global Assessment Scale; SPAI-C/P = Social Phobia and Anxiety Inventory for Children- 
Child/Parent ; SCAS-C/P = Spence Children’s Anxiety Scale - Child/Parent; SSQ-C/P= Social Skills Questionnaire- Child/Parent; PEPQ-R = Post Event Processing Questionnaire- Revised 
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Figure 1. Flow diagram showing the progression of participants through the study. 
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Figure 1. Flow diagram showing the progression of participants through the study. 
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Highlights 
 
1. There was no significant difference in outcome between generic and disorder-
specific CBT for SAD in youth. Both treatments, using internet delivery with 
brief therapist assistance, showed significantly greater reductions in social 
anxiety than a wait list control.  
2. Post-event processing mediated reductions in social anxiety for both generic 
and disorder-specific CBT supporting the importance of this construct as an 
underlying mechanism of therapeutic change in the treatment of SAD. 
3. Despite significant reductions in social anxiety and improvements in social 
functioning following CBT, the majority of youth in both conditions continued 
to meet criteria for a clinical diagnosis of SAD. This indicates the challenges in 
treating SAD in young people, and reflected the high initial severity of social 
anxiety symptoms and poor adaptive functioning of the sample in this study.  
 
 
 
